By Mill Chart
Last update: Nov 29, 2022
Let's have a look at the stocks with an unusual volume in today's session.
Ticker | Change | Comment |
---|---|---|
ONCS | 22.75% | ONCOSEC MEDICAL INC (NASDAQ:ONCS) has an unusual volume of 13.6M shares. Shares are rising by 22.75%. The average volume measured over 50 days is 421.56K, so this is 3.0K% above the average volume. |
NAOV | -20.16% | NANOVIBRONIX INC (NASDAQ:NAOV) has an unusual volume of 22.94M shares. NASDAQ:NAOV is declining 20.16% today. The average daily volume over 50 days is 1.04M, so this is 2.0K% above the average volume. A press release (NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus) was released yesterday. |
MANU | 2.59% | MANCHESTER UNITED PLC-CL A's (NYSE:MANU) traded a high volume of 2.89M shares. The share price increased by 2.59%. This volume is 65.14% above the average 50 day volume. |
NBRV | -4.81% | So far 257.22K shares of NABRIVA THERAPEUTICS PLC (NASDAQ:NBRV) have traded in today's session. Leading to a price decrease of 4.81%. This volume is 112.0% above the average 50 day volume. |
TBLA | -3.03% | So far 5.24M shares of TABOOLA.COM LTD (NASDAQ:TBLA) have traded in today's session. NASDAQ:TBLA is declining 3.03% today. The average daily volume over 50 days is 2.46M, so this is 113.0% above the average volume. |
WISA | -14.95% | WISA TECHNOLOGIES INC (NASDAQ:WISA) has an unusual volume of 3.91M shares. NASDAQ:WISA is declining 14.95% today. The average daily volume over 50 days is 443.57K, so this is 782.0% above the average volume. |
ICAD | -5.79% | ICAD INC's (NASDAQ:ICAD) traded a high volume of 205.6K shares. The share price decreased by 5.79%. The average volume measured over 50 days is 169.18K, so this is 21.53% above the average volume. |
VEON | -3.35% | VEON LTD (NASDAQ:VEON) has an unusual volume of 1.77M shares today. The share price decreased by 3.35%. The average volume measured over 50 days is 624.9K, so this is 183.0% above the average volume. |
HMCO | 0.15% | So far 312.99K shares of HUMANCO ACQUISITION COR-CL A (NASDAQ:HMCO) have traded in today's session. Shares are rising by 0.15%. The average daily volume over 50 days is 116.42K, so this is 169.0% above the average volume. |
HLBZ | 2.39% | HELBIZ INC (NASDAQ:HLBZ) has an unusual volume of 56.0M shares. Leading to a price increase of 2.39%. The average daily volume over 50 days is 10.95M, so this is 411.0% above the average volume. Earlier today the company had a press release: Wheels, part of Helbiz, Completes Integration with Google. |
Our unusual volume stocks screener will show you the full list.
ICAD INC
NASDAQ:ICAD (5/2/2024, 7:00:03 PM)
After market: 1.49 0 (0%)1.49
+0.06 (+4.2%)
NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions,...
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering...
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast...
Study confirms iCAD’s Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular...
ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection...
These AI stocks will get big boosts from the proliferation of AI over the longer term, but the market is not giving them enough love.
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear...
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
ICAD (ICAD) stock jumped 11% Wednesday after the company said it was making several presentations at the European Congress of Radiology annual meeting this week. Read more here.
Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false...
Dr. Hricak offers extensive experience in radiology, real-world application of AI-enabled imaging solutions, research, and global healthcare perspectives...
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical...